Brand name: Novothirteen TM
Active ingredients: catridecacog
What it is used for
NovoThirteen is indicated for routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White lyophilised powder to be reconstituted with solvent for injection, clear glass vial
The way to take this medicine is: Intravenous Bolus.
Part 2: Injection, solvent for
Clear colourless liquid in clear glass vial.
The way to take this medicine is: Intravenous Bolus.
Part 3: Drug delivery system
No information available
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Reconstituted Solution see indications for shelf life
- Refrigerate
- Protect from Light
- Do not Freeze
- Shelf lifetime is 24 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
